Christine I Nichols1, Joshua G Vose1, Ryan M Nunley2. 1. Department of Medical Affairs, Medtronic Advanced Energy, Portsmouth, New Hampshire. 2. Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri.
Abstract
BACKGROUND: In the era of bundled payments, many hospitals are responsible for costs from admission through 90 days postdischarge. Although bundled episodes for hip fracture will have a separate target price for the bundle, little is known about the 90-day resource use burden for this patient population. METHODS: Using Medicare 100% Standard Analytic Files (2010-2014), we identified patients undergoing hemiarthroplasty or total hip arthroplasty (THA). Patients were aged 65 and older with admitting diagnosis of closed hip fracture, no concurrent fractures of the lower limb, and no history of hip surgery in the prior 12 months baseline. Continuous Medicare-only enrollment was required. Complications, resource use, and mortality from admission through 90 days following discharge (follow-up) were summarized. RESULTS: Four cohorts met selection criteria for analysis: (1) hemiarthroplasty diagnosis-related group (DRG) 469 (N = 19,634), (2) hemiarthroplasty DRG 470 (N = 77,744), (3) THA DRG 469 (N = 1686), and (4) THA DRG 470 (N = 9314). All-cause mortality during the study period was 51.6%, 29.5%, 48.1%, and 24.9% with mean 90-day costs of $28,952, $19,243, $29,763, and $18,561, respectively. Most of the patients waited 1 day from admission to surgery (41%-51%). Incidence of an all-cause complication was approximately 70% in each DRG 469 cohort and 14%-16% in each DRG 470 cohort. CONCLUSION: This study confirms patients with hip fracture are a costly subpopulation. Tailored care pathways to minimize post-acute care resource use are warranted for these patients.
BACKGROUND: In the era of bundled payments, many hospitals are responsible for costs from admission through 90 days postdischarge. Although bundled episodes for hip fracture will have a separate target price for the bundle, little is known about the 90-day resource use burden for this patient population. METHODS: Using Medicare 100% Standard Analytic Files (2010-2014), we identified patients undergoing hemiarthroplasty or total hip arthroplasty (THA). Patients were aged 65 and older with admitting diagnosis of closed hip fracture, no concurrent fractures of the lower limb, and no history of hip surgery in the prior 12 months baseline. Continuous Medicare-only enrollment was required. Complications, resource use, and mortality from admission through 90 days following discharge (follow-up) were summarized. RESULTS: Four cohorts met selection criteria for analysis: (1) hemiarthroplasty diagnosis-related group (DRG) 469 (N = 19,634), (2) hemiarthroplasty DRG 470 (N = 77,744), (3) THA DRG 469 (N = 1686), and (4) THA DRG 470 (N = 9314). All-cause mortality during the study period was 51.6%, 29.5%, 48.1%, and 24.9% with mean 90-day costs of $28,952, $19,243, $29,763, and $18,561, respectively. Most of the patients waited 1 day from admission to surgery (41%-51%). Incidence of an all-cause complication was approximately 70% in each DRG 469 cohort and 14%-16% in each DRG 470 cohort. CONCLUSION: This study confirms patients with hip fracture are a costly subpopulation. Tailored care pathways to minimize post-acute care resource use are warranted for these patients.
Authors: Antonio Ziranu; Cesare Meschini; Davide De Marco; Giuseppe Sircana; Maria Serena Oliva; Giusepp Rovere; Andrea Corbingi; Raffaele Vitiello; Giulio Maccauro; Enrico Pola Journal: Orthop Rev (Pavia) Date: 2022-10-13
Authors: Cheryl K Zogg; David Metcalfe; Andrew Judge; Daniel C Perry; Matthew L Costa; Belinda J Gabbe; Andrew J Schoenfeld; Kimberly A Davis; Zara Cooper; Judith H Lichtman Journal: Ann Surg Date: 2022-03-01 Impact factor: 13.787
Authors: Flavia K Borges; Mohit Bhandari; Ameen Patel; Victoria Avram; Ernesto Guerra-Farfán; Alben Sigamani; Masood Umer; Maria Tiboni; Anthony Adili; John Neary; Vikas Tandon; Parag K Sancheti; AbdelRahman Lawendy; Richard Jenkinson; Mmampapatla Ramokgopa; Bruce M Biccard; Wojciech Szczeklik; Chew Yin Wang; Giovanni Landoni; Patrice Forget; Ekaterine Popova; Gavin Wood; Aamer Nabi Nur; Bobby John; Paweł Ślęczka; Robert J Feibel; Mariano Balaguer-Castro; Benjamin Deheshi; Mitchell Winemaker; Justin de Beer; Richard Kolesar; Jordi Teixidor-Serra; Jordi Tomas-Hernandez; Michael McGillion; Harsha Shanthanna; Iain Moppett; Jessica Vincent; Shirley Pettit; Valerie Harvey; Leslie Gauthier; Kim Alvarado; P J Devereaux Journal: BMJ Open Date: 2019-05-01 Impact factor: 2.692
Authors: Jared A Warren; Kavin Sundaram; Hiba K Anis; Nicolas S Piuzzi; Carlos A Higuera; Atul F Kamath Journal: Geriatr Orthop Surg Rehabil Date: 2019-09-20
Authors: Louis de Jong; Veronique A J I M van Rijckevorsel; Jelle W Raats; Taco M A L Klem; Tjallingius M Kuijper; Gert R Roukema Journal: Clin Interv Aging Date: 2019-02-26 Impact factor: 4.458